Few methods have divided opinion so sharply. To some, intermittent fasting is a metabolic revolution; to others, a passing fad. The randomised trials accumulated over the past decade now allow a verdict — less spectacular than the promises, but more useful.
What Are We Actually Talking About?
"Intermittent fasting" is an umbrella term covering very different practices. Time-restricted eating (typically 16/8) compresses the daily eating window. Alternate-day fasting alternates normal days with days of severely reduced intake. The 5:2 and whole-day-fasting formats sharply restrict intake on one or two days a week.
These protocols share neither the same constraints nor the same results, which explains much of the confusion in public debate.
The Verdict From the Large Syntheses
The broadest systematic review to date was published in The BMJ in June 2025. It pooled 99 randomised trials covering 6,582 adults, median age 45, mostly female, with a median BMI of 31.3, and nearly 90% living with an existing health condition. Trials ran from 3 to 52 weeks.
The headline conclusion: all intermittent fasting strategies and continuous energy restriction produce small weight reductions compared with unrestricted eating. Alternate-day fasting was the only approach to show an added benefit over continuous restriction, around 1.29 kg on average — an advantage that disappeared in trials of 24 weeks or longer. Time-restricted eating, the format most people actually follow day to day, did not outperform conventional calorie counting.
An earlier meta-analysis of eleven trials had already concluded that intermittent and continuous approaches produced comparable weight loss, with a slight reduction in fasting insulin whose clinical relevance remained uncertain.
Why It Works When It Works
The most robust explanation is mundane: narrowing the eating window or skipping meals mechanically reduces total intake. Fasting is not a magic metabolic mechanism; it is a structuring tool. For some people, removing one food decision per day is simpler than measuring every portion. For others, the reverse is true.
Who It Is Not For
- A history of eating disorders. Rigid rules and periods of deprivation are recognised risk factors.
- Pregnancy and breastfeeding.
- Treated diabetes, particularly on insulin or sulfonylureas: hypoglycaemia risk, medical adjustment essential.
- Adolescents, frail older adults, undernutrition: the muscle-loss risk outweighs the benefit.
- Medication requiring regular food intake, to be checked with the prescribing doctor.
- Intense physical training, where the distribution of protein intake matters.
- Any situation where fasting becomes an obsession rather than a practical framework — that is the stop signal.
The Takeaway
Intermittent fasting works about as well as conventional calorie restriction, no better and no worse. It is therefore neither a miracle nor a fraud: it is one option among several, whose main merit is ease of implementation for certain profiles. The best method is still the one you will be following a year from now — and no meta-analysis can answer that question on your behalf.
Sources
- Semnani-Azad Z. et al., Intermittent fasting strategies and their effects on body weight and other cardiometabolic risk factors: systematic review and network meta-analysis of randomised clinical trials, BMJ 2025;389:e082007: https://pmc.ncbi.nlm.nih.gov/articles/PMC12175170/
- BMJ Group press summary of the analysis: https://bmjgroup.com/intermittent-fasting-comparable-to-traditional-diets-for-weight-loss/
- Cioffi I. et al., Intermittent versus continuous energy restriction on weight loss and cardiometabolic outcomes: a systematic review and meta-analysis of randomized controlled trials: https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6304782/
- Anses, Régimes amaigrissants : des pratiques à risque: https://www.anses.fr/fr/content/regimes-amaigrissants-des-pratiques-risque
